End stage hip disease
Conditions
Interventions
Group A:Bone wax closes the medullary cavity
Group B:Bone wax is not used intraoperatively
Sponsors
West China Hospital, Sichuan University
Eligibility
Sex/Gender
Male
Age
20 Years to 85 Years
Inclusion criteria
Inclusion criteria: 1. Patients requiring primary total hip arthroplasty due to severe hip osteoarthritis, femoral head necrosis, and secondary osteoarthritis due to developmental hip dysplasia; 2. Aged between 20 and 80 years; 3. Body mass index is between 18.5 and 29.9 kg/m2; 4. The American Society of Anesthesiologists (American Society of Anesthesiologists, ASA) classification (anesthesia risk assessment) I to III levels; 5. Preoperative blood routine and blood coagulation function were normal
Exclusion criteria
Exclusion criteria: 1. Allergic to bone wax and tranexamic acid; 2. Previous thrombosis events, cardiovascular or cerebrovascular history, coagulation dysfunction, and severe liver and kidney dysfunction; 3. History of hip injury and infection; 4. Receiving anticoagulant therapy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood loss; | — |
Countries
China
Contacts
Public ContactKang Pengde
West China Hospital, Sichuan University
Outcome results
None listed